Vladislav Sandler - Hemogenyx Pharmaceuticals CEO CoFounder
| HEMO Stock | 343.40 20.90 6.48% |
CEO
Vladislav Sandler is CEO CoFounder of Hemogenyx Pharmaceuticals PLC
| Age | 59 |
| Address | 60 Gracechurch Street, London, United Kingdom, EC3V 0HR |
| Phone | 44 79 0917 7311 |
| Web | https://hemogenyx.com |
Hemogenyx Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3779) % which means that it has lost $0.3779 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5597) %, meaning that it generated substantial loss on money invested by shareholders. Hemogenyx Pharmaceuticals' management efficiency ratios could be used to measure how well Hemogenyx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hemogenyx Pharmaceuticals' Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 9.4 M in 2024, whereas Total Current Assets are likely to drop slightly above 2.1 M in 2024.Similar Executives
| Found 7 records | CEO Age | ||
| David Gibbs | Yum Brands | 61 | |
| Rene Haas | SoftBank Group Corp | 62 | |
| Koji Sato | Toyota Motor Corp | 55 | |
| Akio Toyoda | Toyota Motor Corp | 68 | |
| Gill Pratt | Toyota Motor Corp | N/A | |
| Pierce II | ONEOK Inc | 64 | |
| Ralph LaRossa | Public Service Enterprise | 61 | |
Management Performance
| Return On Equity | -1.56 | ||||
| Return On Asset | -0.38 |
Hemogenyx Pharmaceuticals Leadership Team
Elected by the shareholders, the Hemogenyx Pharmaceuticals' board of directors comprises two types of representatives: Hemogenyx Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hemogenyx. The board's role is to monitor Hemogenyx Pharmaceuticals' management team and ensure that shareholders' interests are well served. Hemogenyx Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hemogenyx Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vladislav Sandler, CEO CoFounder | ||
| Alexis JD, Independent Director | ||
| Koen MD, Clinical Director | ||
| Ben Harber, Company Secretary | ||
| Andrew Wright, Financial Sec |
Hemogenyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hemogenyx Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.56 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 13.18 M | ||||
| Shares Outstanding | 3.5 M | ||||
| Shares Owned By Insiders | 10.27 % | ||||
| Shares Owned By Institutions | 0.79 % | ||||
| Price To Book | 3.93 X | ||||
| EBITDA | (5.73 M) | ||||
| Net Income | (6.69 M) | ||||
| Total Debt | 2.95 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.